The dataset-based cancer genome study from 482 invasive BC patients showed that 27.4% of CDK4/6–RB axis genetic deregulation involves either the expression of single gene alteration or multiple gene alterations in combination [101]. This evidence concerns the gene CDK4 and cancer.